US2006173075A1PendingUtilityA1
P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents
Individually held — no corporate assignee on recordPriority: Apr 28, 2000Filed: Mar 2, 2006Published: Aug 3, 2006
Est. expiryApr 28, 2020(expired)· nominal 20-yr term from priority
A61P 37/06A61P 37/02A61P 43/00A61P 3/10A61P 29/00A61P 25/28C07C 323/36C07D 213/38C07D 231/12C07D 333/20C07D 249/08C07D 277/64C07D 237/14A61P 19/02C07D 213/64C07D 207/14C07D 277/28A61P 19/06C07D 213/74C07C 317/36C07D 233/56A61P 21/00C07D 237/12C07D 207/27
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to anti-inflammatory and analgesic compounds, especially to certain p-(sulfonyl)phenyl amino derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Claims
exact text as granted — not AI-modified1 . A compound selected from the group of compounds represented by formula (I):
wherein:
A is —(CR 2 ) n — where n is 1, 2, or 3 and R is independently hydrogen or alkyl;
B is aryl or heteroaryl;
R 1 is alkyl, alkenyl, cyanoalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaralkyl, heterocyclyl, heterocyclylalkyl, heteroalkyl or alkylcarbonylalkyl;
R 2 is NR 13 R 14 wherein:
R 13 is hydrogen or alkyl;
R 14 is hydrogen, alkyl, alkenyl, acyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aralkyl, hydroxyalkyl, alkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, or aminoalkyl;
R 3 is hydrogen, alkyl, halo, nitro, cyano, hydroxy, alkoxy;
and pharmaceutically acceptable salts thereof.
2 . The compound of claim 1 , wherein:
R 3 is hydrogen.
3 . The compound of claim 2 wherein B is aryl.
4 . The compound of claim 3 wherein B is optionally substituted phenyl.
5 . The compound of claim 4 wherein R 1 is alkyl, cycloalkyl, cycloalkyl-alkyl, heterocyclyl, heterocyclylalkyl or heteroalkyl.
6 . The compound of claim 5 wherein R 1 is heteroalkyl.
7 . The compound of claim 6 wherein R 1 is alkylsulfonylalkyl.
8 . (canceled)
9 . The compound of claim 1 wherein A is —(CH 2 )—.
10 . The compound of claim 7 wherein R 13 and R 14 are hydrogen.
11 . The compound of claim 10 wherein A is —(CH 2 )—.
12 . The compound of claim 2 wherein B is heteroaryl.
13 . The compound of claim 12 wherein R 1 is alkyl, cycloalkyl, cycloalkyl-alkyl, heterocyclyl, heterocyclylalkyl or heteroalkyl.
14 . The compound of claim 13 wherein R 1 is heteroalkyl.
15 . The compound of claim 14 wherein R 1 is alkylsulfonylalkyl.
16 - 17 . (canceled)
18 . The compound of claim 15 wherein R 13 and R 14 are hydrogen.
19 . The compound of claim 18 wherein A is —(CH 2 )—.
20 - 37 . (canceled)
38 . The compound of claim 1 wherein:
R 1 is alkylsulfonylalkyl; and B is aryl.
39 - 40 . (canceled)
41 . The compound of claim 38 , wherein R 2 is NH 2 .
42 . The compound of claim 41 , wherein A is —(CH 2 )—.
43 - 49 . (canceled)Join the waitlist — get patent alerts
Track US2006173075A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.